Edition:
United Kingdom

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

99.00EUR
1:35pm GMT
Change (% chg)

€0.64 (+0.65%)
Prev Close
€98.36
Open
€98.40
Day's High
€99.10
Day's Low
€98.26
Volume
135,414
Avg. Vol
561,947
52-wk High
€100.75
52-wk Low
€74.54

Chart for

About

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and... (more)

Overall

Beta: 1.01
Market Cap(Mil.): €12,352.97
Shares Outstanding(Mil.): 129.24
Dividend: 1.20
Yield (%): 1.26

Financials

  MRCG.DE Industry Sector
P/E (TTM): 24.91 29.30 32.54
EPS (TTM): 3.84 -- --
ROI: 5.93 14.23 13.82
ROE: 12.78 15.46 15.25

Merck KGaA calls on Versum investors to vote down Entegris merger

FRANKFURT Merck KGaA on Tuesday reiterated its recommendation to shareholders of its takeover target Versum to reject the electronic materials maker's planned merger with peer Entegris.

12 Mar 2019

Merck KGaA calls on Versum investors to vote down Entegris merger

FRANKFURT Merck KGaA on Tuesday reiterated its recommendation to shareholders of its takeover target Versum to reject the electronic materials maker's planned merger with peer Entegris.

12 Mar 2019

Merck KGaA calls on Versum investors to vote down Entegris merger

FRANKFURT, March 12 Merck KGaA on Tuesday reiterated its recommendation to shareholders of its takeover target Versum to reject the electronic materials maker's planned merger with peer Entegris.

12 Mar 2019

Versum, Entegris see extra merger benefits, Merck hires Goldman

FRANKFURT Entegris and Versum Materials on Friday highlighted additional benefits from their planned all-share merger, while rival bidder Merck KGaA said it had brought in Goldman Sachs to help with its counter offer.

08 Mar 2019

Versum, Entegris see extra merger benefits, Merck hires Goldman

FRANKFURT Entegris and Versum Materials on Friday highlighted additional benefits from their planned all-share merger, while rival bidder Merck KGaA said it had brought in Goldman Sachs to help with its counter offer.

08 Mar 2019

UPDATE 1-Versum, Entegris see extra merger benefits, Merck hires Goldman

FRANKFURT, March 8 Entegris and Versum Materials on Friday highlighted additional benefits from their planned all-share merger, while rival bidder Merck KGaA said it had brought in Goldman Sachs to help with its counter offer.

08 Mar 2019

Merck KGaA mandates Goldman as additional advisor for Versum deal

FRANKFURT, March 8 German drugs and lab supplies group Merck KGaA has brought in Goldman Sachs as additional advisor for its unsolicited bid for Versum Materials as it seeks to break up the U.S. company's agreed merger with a rival suitor.

08 Mar 2019

Merck KGaA encouraged by market reaction to Versum swoop

DARMSTADT, Germany German drugs and lab supplies group Merck KGaA is encouraged by the market reaction to its unsolicited bid for Versum, as it seeks to break up the U.S. company's agreed merger with a rival suitor, Merck said on Thursday.

07 Mar 2019

Merck KGaA encouraged by market reaction to Versum swoop

DARMSTADT, Germany German drugs and lab supplies group Merck KGaA is encouraged by the market reaction to its unsolicited bid for Versum, as it seeks to break up the U.S. company's agreed merger with a rival suitor, Merck said on Thursday.

07 Mar 2019

UPDATE 2-Merck KGaA encouraged by market reaction to Versum swoop

* Established drugs see strong gains in emerging markets (Releads on CEO comments on Versum)

07 Mar 2019

Earnings vs. Estimates